
NEXPHORIA
KPV
Alpha-MSH C-terminal tripeptide. Potent anti-inflammatory and gut health research.
Purchase Type
Fresh cold-chain delivery every 30 days
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
KPV (Lys-Pro-Val) is the biologically active C-terminal tripeptide of alpha-melanocyte-stimulating hormone (alpha-MSH). Research by Catania and colleagues demonstrated that this minimal fragment retains the full anti-inflammatory and antipyretic activity of the parent peptide. KPV's small size enables oral bioavailability and intestinal permeability, making it particularly relevant for gastrointestinal inflammation research.
Complete Your Protocol
Related compounds.
Side-by-Side Analysis
Compare KPV with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.

Recovery & Healing
This itemKPV
10mg
$58

Recovery & Healing
RecommendedBPC-157
5mg
$50

Wellness
LL-37
5mg
$72
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
Peptide Research for Arthritis and Joint Inflammation: BPC-157, KPV, TB-500, and GHK-Cu Protocol Design
A comprehensive research protocol guide for arthritis and joint inflammation models. Covers BPC-157, KPV, TB-500, and GHK-Cu mechanisms, validated animal models (CIA, AIA, ACLT), endpoint selection, multi-compound study design, and critical controls.
KPV: The Immunomodulatory Tripeptide
A research-focused guide to KPV — its origin as the C-terminal fragment of alpha-MSH, MC1R/MC3R binding without pigmentation, NF-κB inhibition, anti-inflammatory cytokine suppression, intestinal mucosal research models, oral stability, and design considerations for immunology and GI research.
Peptide Research for Inflammation: COX-2, NF-κB, and Anti-Inflammatory Protocol Design
Comprehensive guide to designing preclinical anti-inflammatory peptide research studies. Covers COX-2/PGE₂ pathway, NF-κB signaling, key compounds (BPC-157, KPV, TB-500, LL-37, GHK-Cu), model selection, endpoint panels, and critical pharmacological controls.
Complete Your Protocol
Gut Health Protocol
KPV's anti-inflammatory and gut-barrier properties synergize with BPC-157's cytoprotective effects for gastrointestinal research protocols.

Recovery & Healing
KPV
10mg
$58

Recovery & Healing
BPC-157
5mg
$50
